User menu

Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, France.

Bibliographic reference Desoubeaux, Guillaume ; Reichert, Janice M ; Sleeman, Matthew ; Reckamp, Karen L ; Ryffel, Bernhard ; et. al. Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, France.. In: mAbs, Vol. 8, no. 6, p. 999-1009 (2016)
Permanent URL http://hdl.handle.net/2078.1/174768
  1. Reichert Janice M., Antibodies to watch in 2016, 10.1080/19420862.2015.1125583
  2. Traub Stephanie, Nikonova Alexandra, Carruthers Alan, Dunmore Rebecca, Vousden Katherine A., Gogsadze Leila, Hao Weidong, Zhu Qing, Bernard Katie, Zhu Jie, Dymond Michael, McLean Gary R., Walton Ross P., Glanville Nicholas, Humbles Alison, Khaitov Musa, Wells Ted, Kolbeck Roland, Leishman Andrew J., Sleeman Matthew A., Bartlett Nathan W., Johnston Sebastian L., An Anti-Human ICAM-1 Antibody Inhibits Rhinovirus-Induced Exacerbations of Lung Inflammation, 10.1371/journal.ppat.1003520
  3. Turner Ronald B., Wecker Margaret T., Pohl Gerhardt, Witek Theodore J., McNally Eugene, St. George Roger, Winther Birgit, Hayden Frederick G., Efficacy of Tremacamra, a Soluble Intercellular Adhesion Molecule 1, for Experimental Rhinovirus Infection : A Randomized Clinical Trial, 10.1001/jama.281.19.1797
  4. Kearley Jennifer, Silver Jonathan S., Sanden Caroline, Liu Zheng, Berlin Aaron A., White Natalie, Mori Michiko, Pham Tuyet-Hang, Ward Christine K., Criner Gerard J., Marchetti Nathaniel, Mustelin Tomas, Erjefalt Jonas S., Kolbeck Roland, Humbles Alison A., Cigarette Smoke Silences Innate Lymphoid Cell Function and Facilitates an Exacerbated Type I Interleukin-33-Dependent Response to Infection, 10.1016/j.immuni.2015.02.011
  5. Cohen E. Suzanne, Scott Ian C., Majithiya Jayesh B., Rapley Laura, Kemp Benjamin P., England Elizabeth, Rees D. Gareth, Overed-Sayer Catherine L., Woods Joanne, Bond Nicholas J., Veyssier Christel Séguy, Embrey Kevin J., Sims Dorothy A., Snaith Michael R., Vousden Katherine A., Strain Martin D., Chan Denice T. Y., Carmen Sara, Huntington Catherine E., Flavell Liz, Xu Jianqing, Popovic Bojana, Brightling Christopher E., Vaughan Tristan J., Butler Robin, Lowe David C., Higazi Daniel R., Corkill Dominic J., May Richard D., Sleeman Matthew A., Mustelin Tomas, Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation, 10.1038/ncomms9327
  6. Horn M. P., Zuercher A. W., Imboden M. A., Rudolf M. P., Lazar H., Wu H., Hoiby N., Fas S. C., Lang A. B., Preclinical In Vitro and In Vivo Characterization of the Fully Human Monoclonal IgM Antibody KBPA101 Specific for Pseudomonas aeruginosa Serotype IATS-O11, 10.1128/aac.01142-09
  7. Secher T., Fauconnier L., Szade A., Rutschi O., Fas S. C., Ryffel B., Rudolf M. P., Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection, 10.1093/jac/dkr038
  8. Secher Thomas, Fas Stefanie, Fauconnier Louis, Mathieu Marieke, Rutschi Oliver, Ryffel Bernhard, Rudolf Michael, The Anti-Pseudomonas aeruginosa Antibody Panobacumab Is Efficacious on Acute Pneumonia in Neutropenic Mice and Has Additive Effects with Meropenem, 10.1371/journal.pone.0073396
  9. Que Y.-A., Lazar H., Wolff M., François B., Laterre P.-F., Mercier E., Garbino J., Pagani J.-L., Revelly J.-P., Mus E., Perez A., Tamm M., Rouby J.-J., Lu Q., Chastre J., Eggimann P., Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia, 10.1007/s10096-014-2156-1
  10. Sandler Alan, Gray Robert, Perry Michael C., Brahmer Julie, Schiller Joan H., Dowlati Afshin, Lilenbaum Rogerio, Johnson David H., Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer, 10.1056/nejmoa061884
  11. Reck Martin, von Pawel Joachim, Zatloukal Petr, Ramlau Rodryg, Gorbounova Vera, Hirsh Vera, Leighl Natasha, Mezger Jörg, Archer Venice, Moore Nicola, Manegold Christian, Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL, 10.1200/jco.2007.14.5466
  12. Garon Edward B, Ciuleanu Tudor-Eliade, Arrieta Oscar, Prabhash Kumar, Syrigos Konstantinos N, Goksel Tuncay, Park Keunchil, Gorbunova Vera, Kowalyszyn Ruben Dario, Pikiel Joanna, Czyzewicz Grzegorz, Orlov Sergey V, Lewanski Conrad R, Thomas Michael, Bidoli Paolo, Dakhil Shaker, Gans Steven, Kim Joo-Hang, Grigorescu Alexandru, Karaseva Nina, Reck Martin, Cappuzzo Federico, Alexandris Ekaterine, Sashegyi Andreas, Yurasov Sergey, Pérol Maurice, Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial, 10.1016/s0140-6736(14)60845-x
  13. Thatcher Nick, Hirsch Fred R, Luft Alexander V, Szczesna Aleksandra, Ciuleanu Tudor E, Dediu Mircea, Ramlau Rodryg, Galiulin Rinat K, Bálint Beatrix, Losonczy György, Kazarnowicz Andrzej, Park Keunchil, Schumann Christian, Reck Martin, Depenbrock Henrik, Nanda Shivani, Kruljac-Letunic Anamarija, Kurek Raffael, Paz-Ares Luis, Socinski Mark A, Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial, 10.1016/s1470-2045(15)00021-2
  14. Paz-Ares Luis, Mezger Jörg, Ciuleanu Tudor E, Fischer Jürgen R, von Pawel Joachim, Provencio Mariano, Kazarnowicz Andrzej, Losonczy György, de Castro Gilberto, Szczesna Aleksandra, Crino Lucio, Reck Martin, Ramlau Rodryg, Ulsperger Ernst, Schumann Christian, Miziara Jose Elias A, Lessa Álvaro E, Dediu Mircea, Bálint Beatrix, Depenbrock Henrik, Soldatenkova Victoria, Kurek Raffael, Hirsch Fred R, Thatcher Nick, Socinski Mark A, Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study, 10.1016/s1470-2045(15)70046-x
  15. Brahmer Julie, Reckamp Karen L., Baas Paul, Crinò Lucio, Eberhardt Wilfried E.E., Poddubskaya Elena, Antonia Scott, Pluzanski Adam, Vokes Everett E., Holgado Esther, Waterhouse David, Ready Neal, Gainor Justin, Arén Frontera Osvaldo, Havel Libor, Steins Martin, Garassino Marina C., Aerts Joachim G., Domine Manuel, Paz-Ares Luis, Reck Martin, Baudelet Christine, Harbison Christopher T., Lestini Brian, Spigel David R., Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer, 10.1056/nejmoa1504627
  16. Borghaei Hossein, Paz-Ares Luis, Horn Leora, Spigel David R., Steins Martin, Ready Neal E., Chow Laura Q., Vokes Everett E., Felip Enriqueta, Holgado Esther, Barlesi Fabrice, Kohlhäufl Martin, Arrieta Oscar, Burgio Marco Angelo, Fayette Jérôme, Lena Hervé, Poddubskaya Elena, Gerber David E., Gettinger Scott N., Rudin Charles M., Rizvi Naiyer, Crinò Lucio, Blumenschein George R., Antonia Scott J., Dorange Cécile, Harbison Christopher T., Graf Finckenstein Friedrich, Brahmer Julie R., Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer, 10.1056/nejmoa1507643
  17. Herbst Roy S, Baas Paul, Kim Dong-Wan, Felip Enriqueta, Pérez-Gracia José L, Han Ji-Youn, Molina Julian, Kim Joo-Hang, Arvis Catherine Dubos, Ahn Myung-Ju, Majem Margarita, Fidler Mary J, de Castro Gilberto, Garrido Marcelo, Lubiniecki Gregory M, Shentu Yue, Im Ellie, Dolled-Filhart Marisa, Garon Edward B, Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial, 10.1016/s0140-6736(15)01281-7
  18. Garon Edward B., Rizvi Naiyer A., Hui Rina, Leighl Natasha, Balmanoukian Ani S., Eder Joseph Paul, Patnaik Amita, Aggarwal Charu, Gubens Matthew, Horn Leora, Carcereny Enric, Ahn Myung-Ju, Felip Enriqueta, Lee Jong-Seok, Hellmann Matthew D., Hamid Omid, Goldman Jonathan W., Soria Jean-Charles, Dolled-Filhart Marisa, Rutledge Ruth Z., Zhang Jin, Lunceford Jared K., Rangwala Reshma, Lubiniecki Gregory M., Roach Charlotte, Emancipator Kenneth, Gandhi Leena, Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer, 10.1056/nejmoa1501824
  19. Fehrenbacher L, Lancet Lond Engl (2016)
  20. Verdoliva Antonio, Bellofiore Piero, Rivieccio Vincenzo, Catello Sergio, Colombo Maurizio, Albertoni Claudio, Rosi Antonio, Leoni Barbara, Anastasi Anna Maria, De Santis Rita, Biochemical and Biological Characterization of a New Oxidized Avidin with Enhanced Tissue Binding Properties, 10.1074/jbc.m109.080457
  21. De Santis Rita, Rosi Antonio, Maria Anastasi Anna, Chiapparino Caterina, Albertoni Claudio, Leoni Barbara, Pelliccia Angela, Santapaola Daniela, Carollo Valeria, Marra Emanuele, Aurisicchio Luigi, Arseni Brunilde, Lucrezia Pacello Maria, Palmieri Gabriella, Battella Simone, Petronzelli Fiorella, Maria Milazzo Ferdinando, Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab, 10.18632/oncotarget.2409
  22. Bruchard Mélanie, Rebé Cédric, Derangère Valentin, Togbé Dieudonnée, Ryffel Bernhard, Boidot Romain, Humblin Etienne, Hamman Arlette, Chalmin Fanny, Berger Hélène, Chevriaux Angélique, Limagne Emeric, Apetoh Lionel, Végran Frédérique, Ghiringhelli François, Corrigendum: The receptor NLRP3 is a transcriptional regulator of TH2 differentiation, 10.1038/ni1215-1292a
  23. Besnard A.-G., Togbe D., Couillin I., Tan Z., Zheng S. G., Erard F., Le Bert M., Quesniaux V., Ryffel B., Inflammasome-IL-1-Th17 response in allergic lung inflammation, 10.1093/jmcb/mjr042
  24. Madouri Fahima, Guillou Noëlline, Fauconnier Louis, Marchiol Tiffany, Rouxel Nathalie, Chenuet Pauline, Ledru Aurélie, Apetoh Lionel, Ghiringhelli François, Chamaillard Mathias, Zheng Song Guo, Trovero Fabrice, Quesniaux Valérie F.J., Ryffel Bernhard, Togbe Dieudonnée, Caspase-1 activation by NLRP3 inflammasome dampens IL-33-dependent house dust mite-induced allergic lung inflammation, 10.1093/jmcb/mjv012
  25. Lamas Bruno, Richard Mathias L, Leducq Valentin, Pham Hang-Phuong, Michel Marie-Laure, Da Costa Gregory, Bridonneau Chantal, Jegou Sarah, Hoffmann Thomas W, Natividad Jane M, Brot Loic, Taleb Soraya, Couturier-Maillard Aurélie, Nion-Larmurier Isabelle, Merabtene Fatiha, Seksik Philippe, Bourrier Anne, Cosnes Jacques, Ryffel Bernhard, Beaugerie Laurent, Launay Jean-Marie, Langella Philippe, Xavier Ramnik J, Sokol Harry, CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands, 10.1038/nm.4102
  26. Michaudel C, Am J Clin Exp Immunol, 5, 33 (2016)
  27. Roversi Pietro, Ryffel Bernhard, Togbe Dieudonnée, Maillet Isabelle, Teixeira Mauro, Ahmat Nurfilza, Paesen Guido C., Lissina Olga, Boland Wilhelm, Ploss Kerstin, Caesar Joseph J. E., Leonhartsberger Susanne, Lea Susan M., Nunn Miles A., Bifunctional Lipocalin Ameliorates Murine Immune Complex-induced Acute Lung Injury, 10.1074/jbc.m112.420331
  28. Koussoroplis Salome Juliette, Paulissen Geneviève, Tyteca Donatienne, Goldansaz Hadi, Todoroff Julie, Barilly Céline, Uyttenhove Catherine, Van Snick Jacques, Cataldo Didier, Vanbever Rita, PEGylation of antibody fragments greatly increases their local residence time following delivery to the respiratory tract, 10.1016/j.jconrel.2014.05.021
  29. Goebeler Maria-Elisabeth, Bargou Ralf, Blinatumomab: a CD19/CD3 bispecific T cell engager (BiTE) with unique anti-tumor efficacy, 10.3109/10428194.2016.1161185
  30. Steinmetz Anke, Vallée François, Beil Christian, Lange Christian, Baurin Nicolas, Beninga Jochen, Capdevila Cécile, Corvey Carsten, Dupuy Alain, Ferrari Paul, Rak Alexey, Wonerow Peter, Kruip Jochen, Mikol Vincent, Rao Ercole, CODV-Ig, a universal bispecific tetravalent and multifunctional immunoglobulin format for medical applications, 10.1080/19420862.2016.1162932
  31. Tamura K., Kurihara H., Yonemori K., Tsuda H., Suzuki J., Kono Y., Honda N., Kodaira M., Yamamoto H., Yunokawa M., Shimizu C., Hasegawa K., Kanayama Y., Nozaki S., Kinoshita T., Wada Y., Tazawa S., Takahashi K., Watanabe Y., Fujiwara Y., 64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer, 10.2967/jnumed.112.118612
  32. Dijkers E. C.F., Kosterink J. G.W., Rademaker A. P., Perk L. R., van Dongen G. A.M.S., Bart J., de Jong J. R., de Vries E. G.E., Lub-de Hooge M. N., Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging, 10.2967/jnumed.108.060392
  33. Fick Robert B, Fox Judith A, Jardieu Paula M, Immunotherapy approach to allergic disease, 10.1016/s0162-3109(00)00229-0
  34. FAHY JOHN V., COCKCROFT DONALD W., BOULET LOUIS-PHILIPPE, WONG HOFER H., DESCHESNES FRANCINE, DAVIS ELIZABETH E., RUPPEL JANE, SU JOHN Q., ADELMAN DANIEL C., Effect of Aerosolized Anti-IgE (E25) on Airway Responses to Inhaled Allergen in Asthmatic Subjects, 10.1164/ajrccm.160.3.9810012
  35. Guilleminault L, J Control Release (2014)
  36. Lightwood Daniel, O'Dowd Victoria, Carrington Bruce, Veverka Vaclav, Carr Mark D., Tservistas Markus, Henry Alistair J., Smith Bryan, Tyson Kerry, Lamour Sabrina, Sarkar Kaushik, Turner Alison, Lawson Alastair D., Bourne Tim, Gozzard Neil, Palframan Roger, The Discovery, Engineering and Characterisation of a Highly Potent Anti-Human IL-13 Fab Fragment Designed for Administration by Inhalation, 10.1016/j.jmb.2012.11.036
  37. Detalle Laurent, Stohr Thomas, Palomo Concepción, Piedra Pedro A., Gilbert Brian E., Mas Vicente, Millar Andrena, Power Ultan F., Stortelers Catelijne, Allosery Koen, Melero José A., Depla Erik, Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection, 10.1128/aac.01802-15
  38. Murphy KM, Travers P, Walport M. Janeway's Immunobiology. Seven edition. New York: Garland Science; 2007.
  39. Pelaia Girolamo, Vatrella Alessandro, Maselli Rosario, The potential of biologics for the treatment of asthma, 10.1038/nrd3792
  40. Nelson Aaron L, Reichert Janice M, Development trends for therapeutic antibody fragments, 10.1038/nbt0409-331
  41. Maillet Agnès, Congy-Jolivet Nicolas, Le Guellec Sandrine, Vecellio Laurent, Hamard Sophie, Courty Yves, Courtois Anthony, Gauthier Francis, Diot Patrice, Thibault Gilles, Lemarié Etienne, Heuzé-Vourc’h Nathalie, Aerodynamical, Immunological and Pharmacological Properties of the Anticancer Antibody Cetuximab Following Nebulization, 10.1007/s11095-007-9481-3
  42. Respaud Renaud, Marchand Denis, Parent Christelle, Pelat Thibaut, Thullier Philippe, Tournamille Jean-François, Viaud-Massuard Marie-Claude, Diot Patrice, Si-Tahar Mustapha, Vecellio Laurent, Heuzé-Vourc’h Nathalie, Effect of formulation on the stability and aerosol performance of a nebulized antibody, 10.4161/mabs.29938
  43. Hervé Virginie, Rabbe Nathalie, Guilleminault Laurent, Paul Flora, Schlick Laurène, Azzopardi Nicolas, Duruisseaux Michael, Fouquenet Delphine, Montharu Jérôme, Redini Françoise, Paintaud Gilles, Lemarié Etienne, Cadranel Jacques, Wislez Marie, Heuzé-Vourc’h Nathalie, VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations, 10.4161/mabs.34454
  44. Laucho-Contreras Maria E., Taylor Katherine L., Mahadeva Ravi, Boukedes Steve S., Owen Caroline A., Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice, 10.3791/52236
  45. Lee Ji-Hyun, Lee Dong-Soon, Kim Eun-Kyung, Choe Kang-Hyeon, Oh Yeon-Mock, Shim Tae-Sun, Kim Sang-Eun, Lee Yun-Song, Lee Sang-Do, Simvastatin Inhibits Cigarette Smoking–induced Emphysema and Pulmonary Hypertension in Rat Lungs, 10.1164/rccm.200501-041oc
  46. Martorana Piero A., Beume Rolf, Lucattelli Monica, Wollin Lutz, Lungarella Giuseppe, Roflumilast Fully Prevents Emphysema in Mice Chronically Exposed to Cigarette Smoke, 10.1164/rccm.200411-1549oc
  47. Polverino Francesca, Doyle-Eisele Melanie, McDonald Jacob, Wilder Julie A., Royer Christopher, Laucho-Contreras Maria, Kelly Emer M., Divo Miguel, Pinto-Plata Victor, Mauderly Joe, Celli Bartolome R., Tesfaigzi Yohannes, Owen Caroline A., A Novel Nonhuman Primate Model of Cigarette Smoke–Induced Airway Disease, 10.1016/j.ajpath.2014.11.006
  48. Laucho-Contreras Maria E., Polverino Francesca, Gupta Kushagra, Taylor Katherine L., Kelly Emer, Pinto-Plata Victor, Divo Miguel, Ashfaq Naveed, Petersen Hans, Stripp Barry, Pilon Aprile L., Tesfaigzi Yohannes, Celli Bartolome R., Owen Caroline A., Protective role for club cell secretory protein-16 (CC16) in the development of COPD, 10.1183/09031936.00134214
  49. Lundgren R, Eur Respir J, 1, 883 (1988)
  50. Spina Domenico, Page Clive P., Asthma – a need for a rethink?, 10.1016/s0165-6147(02)02022-9
  51. Van Schoor J., Joos G.F., Pauwels R.A, Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research, 10.1034/j.1399-3003.2000.016003514.x
  52. Keir S.D., Spina D., Douglas G., Herd C., Page C.P., Airway responsiveness in an allergic rabbit model, 10.1016/j.vascn.2011.08.003
  53. Minshall Eleanor M., Riccio Maggie M., Herd Caroline M., Douglas Garry J., Seeds Esther A.M., McKenniff Marie G., Sasaki Masahiro, Spina Dom, Page Clive P., A novel animal model for investigating persistent airway hyperresponsiveness, 10.1016/1056-8719(93)90015-7
  54. Keir Sandra, Page Clive, Spina Domenico, Bronchial hyperresponsiveness induced by chronic treatment with albuterol: Role of sensory nerves, 10.1067/mai.2002.126661
  55. Boswell-Smith V., The Pharmacology of Two Novel Long-Acting Phosphodiesterase 3/4 Inhibitors, RPL554 [9,10-Dimethoxy-2(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-Dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4H-pyrimido[6,1-a]isoquinolin-4-one], 10.1124/jpet.105.099192
  56. Franciosi Lui G, Diamant Zuzana, Banner Katharine H, Zuiker Rob, Morelli Nicoletta, Kamerling Ingrid M C, de Kam Marieke L, Burggraaf Jacobus, Cohen Adam F, Cazzola Mario, Calzetta Luigino, Singh Dave, Spina Domenico, Walker Michael J A, Page Clive P, Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials, 10.1016/s2213-2600(13)70187-5
  57. Grandin C., Lucas-Hourani M., Clavel M., Taborik F., Vabret A., Tangy F., Contamin H., Vidalain P.-O., Evidence for an intranasal immune response to human respiratory syncytial virus infection in cynomolgus macaques, 10.1099/vir.0.000039
  58. Grandin Clément, Hourani Marianne-Lucas, Janin Yves L., Dauzonne Daniel, Munier-Lehmann Hélène, Paturet Adeline, Taborik Fabrice, Vabret Astrid, Contamin Hugues, Tangy Frédéric, Vidalain Pierre-Olivier, Respiratory syncytial virus infection in macaques is not suppressed by intranasal sprays of pyrimidine biosynthesis inhibitors, 10.1016/j.antiviral.2015.11.006
  59. Zeitlinger Markus, Müller Markus, Joukhadar Christian, Lung microdialysis—A powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review), 10.1208/aapsj070362
  60. de la Peña Amparo, Liu Ping, Derendorf Hartmut, Microdialysis in peripheral tissues, 10.1016/s0169-409x(00)00106-x